Association between ACE gene I/D polymorphism and atherothrombotic infarction
-
摘要:
目的研究血管紧张素转换酶(ACE)基因I/D多态位点与动脉血栓性脑梗死的关联性及相关机制。 方法选取动脉血栓性脑梗死患者112例和年龄、性别匹配的对照组180例,采用PCR-AFLP技术对ACE基因I/D位点进行分型。 结果单因素分析提示病例组收缩压水平(138.1±19.7 mmHg)显著高于对照组(126.6±20.6 mmHg)(t=4.716,P<0.001);病例组舒张压水平(88.9±10.1 mmHg)显著高于对照组(79.9±10.0 mmHg)(t=7.450,P<0.001)。病例组中ACE基因I/D位点D等位基因频率和DD基因型频率分布均显著高于对照组(等位基因:χ2=4.953,P=0.026; 基因型:χ2=6.303,P=0.043)。病例组和对照组中ACE基因I/D位点基因型DD携带者收缩压及舒张压水平显著高于基因型ID及II携带者。 结论ACE基因I/D位点等位基因D可能是汉族人群动脉血栓性脑梗死遗传易感基因。等位基因D可能通过升高个体血压的机制导致动脉血栓性脑梗死发生。 Abstract:Objective To investigate the relationship between angiotensin converting enzyme (ACE) gene I/D polymorphism and atherothrombotic infarction. Methods 112 patients with atherothrombotic infarction and 180 age, sex-matched healthy subjects were recruited. Genotypes were detected by PCR-AFLP. Results Univariate analysis revealed that systolic blood pressure (SBP) levels for patients (138.1 ± 19.7mm Hg) were significantly higher than those for healthy controls (126.6 ± 20.6 mmHg) (t=4.716, P<0.001), and diastolic blood pressure (DBP) levels for patients (88.9±10.1 mmHg) were significantly higher than those for healthy controls (79.9 ± 10.0 mmHg) (t=7.450, P<0.001). Allele D frequency and distribution of frequency for genotype DD of ACE gene I/D polymorphism for patients were significantly higher than those for healthy controls (allele: x2= 4.953, P=0.026; genotype: x2=6.303, P=0.043). In both groups, the SBP and DBP levels for genotype DD were significantly higher than those for genotype ID and II. Conclusion Allele D of ACE gene I/D polymorphism plays a role in elevating blood pressure and may be a major risk factor for atherothrombotic infarction. -
表 1 病例组与对照组ACE基因I/D 多态位点基因型与等位基因频率分布(%)
组别 基因型① 等位基因② n II ID DD n I D 病例组 112 24 (21.4) 66 (58.9) 22 (19.6) 224 114 (50.9) 110 (49.1) 对照组 180 63 (35.0) 91 (50.6) 26 (14.4) 360 217 (60.3) 143 (39.7) ①χ2=6.303, P=0.043; ②χ2=4.953, P=0.026 表 2 病例组与对照组ACE基因I/D 多态位点基因型与危险因素的关系
危险因素 病例组 对照组 II (n=24) ID (n=66) DD (n=22) II (n=63) ID (n=91) DD (n=26) 收缩压(mmHg) 130.8±19.2 138.0±19.6 146.4±21.1① 121.2±18.4 126.3±20.8 140.7±21.5③ 舒张压(mmHg) 84.0±10.2 88.7±9.8 94.6±10.3② 76.8±9.7 80.9±10.2 84.1±10.8④ ①DDvsID+II: t=2.186, P=0.031; ②DDvsID+II: t=3.010, P=0.003; ③DDvsID+II: t=3.882, P<0.001; ④DDvsID+II: t=2.284, P=0.024 -
[1] 何深文, 黄海威. 血管紧张素转换酶基因多态性与卒中[J]. 国际脑血管病杂志, 2008, 16(12): 947-51. [2] Matarin M, Brown WM, Dena H, et al. Candidate gene polymorphisms for ischemic stroke[J]. Stroke, 2009, 40(11): 3436-42. doi: 10.1161/STROKEAHA.109.558015 [3] Markoula S, Giannopoulos S, Kostoulas C, et al. Gender association of the angiotensin-converting enzyme gene with ischaemic stroke [J]. J Renin Angiotensin Aldosterone Syst, 2011, 12(4): 510-5. doi: 10.1177/1470320310391333 [4] Kalita J, Misra UK, Kumar B, et al. ACE and ADD1 gene in extra and intracranial atherosclerosis in ischaemic stroke[J]. Neurol Res, 2013, 35(4): 429-34. doi: 10.1179/1743132813Y.0000000161 [5] 陈东骊, 张曹进, 符永恒, 等. ACE2基因多态性与高血压合并缺血性脑卒中临床危险因素的相关性[J]. 南方医科大学学报, 2010, 30(8): 1890-2, 1895. http://www.cnki.com.cn/Article/CJFDTOTAL-DYJD201008038.htm [6] Markus HS, Barley J, Lunt R, et al. Angiotensin-converting enzyme gene deletion polymorphism[J]. A new risk factor for lacunar stroke but not carotid atheroma.Stroke, 1995, 26(3): 1329-33. [7] Munshi A, Sultana S, Kaul S, et al. Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke in a South Indian population[J]. J Neurol Sci, 2008, 272(1/2): 132-5. [8] Zhang Z, Xu G, Liu D, et al. Angiotensin-converting enzyme insertion/deletion polymorphism contributesto ischemic stroke risk: a meta-analysis of 50 case-control studies[J]. PLoS One, 2012, 7: e46495. doi: 10.1371/journal.pone.0046495 [9] 姜玉, 宋伟民. 我国汉族人群血管紧张素转换酶基因多态性与原发性高血压关系的Meta分析[J]. 环境与职业医学, 2007, 24(1): 25-7, 31. http://www.cnki.com.cn/Article/CJFDTOTAL-LDYX200701007.htm [10] He SW, Huang HW, Tan SQ, et al. Influence of angiotensin-converting enzyme insertion/deletion polymorphism on nitric oxide production in hypertensives and hypercholesterolaemics[J]. J Clin Pharm Ther, 2011, 36(2): 187-93. doi: 10.1111/jcp.2011.36.issue-2
点击查看大图
表(2)
计量
- 文章访问数: 485
- HTML全文浏览量: 210
- PDF下载量: 1
- 被引次数: 0